AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Lindstedt, KA Wang, YF Shiota, N Saarinen, J Hyytiainen, M Kokkonen, JO Keski-Oja, J Kovanen, PT
Citation: Ka. Lindstedt et al., Activation of paracrine TGF-beta 1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase, FASEB J, 15(8), 2001, pp. 1377-1388

Authors: Inui, H Shiota, N Motoi, Y Ido, Y Inoue, T Kodama, T Ohkawa, Y Ohkawa, H
Citation: H. Inui et al., Metabolism of herbicides and other chemicals in human cytochrome P450 species and in transgenic potato plants co-expressing human CYP1A1, CYP2B6 and CYP2C19, J PESTIC S, 26(1), 2001, pp. 28-40

Authors: Kakizoe, E Shiota, N Tanabe, Y Shimoura, K Kobayashi, Y Okunishi, H
Citation: E. Kakizoe et al., Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice, J INVES DER, 116(1), 2001, pp. 118-123

Authors: Shiota, N Kodama, S Inui, H Ohkawa, H
Citation: N. Shiota et al., Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants, BIOS BIOT B, 64(10), 2000, pp. 2025-2033

Authors: Nakakubo, H Fukuyama, H Nakajima, M Imada, T Uno, S Shiota, N Takai, S Miyazaki, M Nakamura, N
Citation: H. Nakakubo et al., Secretory production of recombinant human chymase as an active form is Pichia pastoris, YEAST, 16(4), 2000, pp. 315-323

Authors: Nakakubo, H Morita, M Imada, T Takai, S Shiota, N Miyazaki, M Nakamura, N
Citation: H. Nakakubo et al., Functional reconstitution of an active recombinant human chymase from Pichia pastoris cell lysate, YEAST, 16(15), 2000, pp. 1387-1396

Authors: Sakai, Y Aoyagi, T Shiota, N Akashi, A Hasegawa, S
Citation: Y. Sakai et al., Complete decomposition of biological waste sludge by thermophilic aerobic bacteria, WATER SCI T, 42(9), 2000, pp. 81-88

Authors: Hasegawa, S Shiota, N Katsura, K Akashi, A
Citation: S. Hasegawa et al., Solubilization of organic sludge by thermophilic aerobic bacteria as a pretreatment for anaerobic digestion, WATER SCI T, 41(3), 2000, pp. 163-169

Authors: Kovanen, PT Lindstedt, KA Shiota, N Kokkonen, JO
Citation: Pt. Kovanen et al., Chymase-dependent angiotensin II formation in human vascular tissue, CIRCULATION, 102(4), 2000, pp. E32-E32

Authors: Miyazaki, M Wada, T Shiota, N Takai, S
Citation: M. Miyazaki et al., Effect of an angiotensin II receptor antagonist, candesartan cilexetil, oncanine intima hyperplasia after balloon injury, J HUM HYPER, 13, 1999, pp. S21-S25

Authors: Takao, K Takai, S Shiota, N Song, KF Nishimura, K Ishihara, T Miyazaki, M
Citation: K. Takao et al., Lack of effect of carbohydrate depletion on some properties of human mast cell chymase, BBA-GEN SUB, 1427(1), 1999, pp. 74-81

Authors: Inui, H Ueyama, Y Shiota, N Okhawa, Y Ohkawa, H
Citation: H. Inui et al., Herbicide metabolism and cross-tolerance in transgenic potato plants expressing human CYP1A1, PEST BIOCH, 64(1), 1999, pp. 33-46

Authors: Miyazaki, M Shiota, N Sakonjo, H Takai, S
Citation: M. Miyazaki et al., Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog, JPN J PHARM, 79(4), 1999, pp. 455-460

Authors: Song, KF Kanehara, H Takai, S Shiota, N Wada, T Inada, Y Miyazaki, M
Citation: Kf. Song et al., Inhibition of the angiotensin II type 1 receptor by TCV-116: Quantitation by in vitro autoradiography, JPN J PHARM, 79(2), 1999, pp. 131-139

Authors: Shiota, N Okunishi, H Takai, S Mikoshiba, I Sakonjo, H Shibata, N Miyazaki, M
Citation: N. Shiota et al., Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery, CIRCULATION, 99(8), 1999, pp. 1084-1090

Authors: Liu, Y Kondo, A Ohkawa, H Shiota, N Fukuda, H
Citation: Y. Liu et al., Bioconversion using immobilized recombinant flocculent yeast cells carrying a fused enzyme gene in an 'intelligent' bioreactor, BIOCH ENG J, 2(3), 1998, pp. 229-235

Authors: Jin, D Takai, S Shiota, N Miyazaki, M
Citation: D. Jin et al., Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II, EUR J PHARM, 361(2-3), 1998, pp. 199-205
Risultati: 1-17 |